Clinical trial
A Multicenter Open Label Phase II Study of Pomalidomide and Dexamethasone in Progressive Relapsed or Refractory Multiple Myeloma Patients With Deletion 17p or Translocation (4;14) Adverse Karyotypic Abnormalities-IFM2010-02
NCT01745640 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Open Label Phase II Study of Pomalidomide and Dexamethasone in Progressive Relapsed or Refractory Multiple Myeloma Patients With Deletion 17p or Translocation (4;14) Adverse Karyotypic Abnormalities-IFM2010-02
- Lead sponsor
- University Hospital, Lille
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 63 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.